HIV/AIDS

More than 33 million people around the world are currently living with human immunodeficiency virus (HIV). While huge progress has been made in increasing access to HIV treatment in the past decade and new HIV infections have substantially declined in some regions, the pandemic continues to outpace efforts to control it. The number of newly infected people each year outnumbers those who gain access to treatment by two to one.

Defeating HIV will require a comprehensive response, and effective programs must be scaled up to treat people already infected and prevent new infections. New tools are also needed to defeat the pandemic, and investment in research and development for new products remains essential. UCSF researchers address issues across the range of HIV/AIDS studies.

Explore Related Topics

Active Projects: 269

Project Investigator
All Topics Start date End date
Relationship Factors and Engagement in HIV Care in Malawi: A Dyadic Investigation HIV/AIDS, Engagement in Care
ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD HIV/AIDS, Opportunistic Infection
Optimizing ACT use for African children in the setting of HIV and malnutrition Francesca Aweeka, PharmD HIV/AIDS, Malaria, Malnutrition, Micronutrients, Food Insecurity
Understanding mobility and sexual mixing in SEARCH communities Carol Camlin, PhD HIV/AIDS, Epidemiology and Surveillance, Risk Reduction and Prevention, Patient and Peer Education
Sustainable approaches to care delivery in Uganda Gabriel Chamie, MD HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diet, Exercise, and Obesity, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
HPTN 082 - Protocol Implementation Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development
HVTN 120 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG HIV/AIDS
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning, Pediatrics, Newborn and Infant Health
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Pediatrics, Newborn and Infant Health, Risk Reduction and Prevention
HepC/HIV website Susan Coffey, MD HIV/AIDS, Infectious Disease
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey Susan Coffey, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
HIV Clinical Fellowship 2018 (Fellow May Baca) Susan Coffey, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
HIVMA Clinical Fellowship Program (Baca) Susan Coffey, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance
Agricultural intervention for food security and HIV health outcomes in Kenya Craig Cohen, MD, MPH HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Health Economics and Effectiveness
East Africa IEDEA Regional Consortium Craig Cohen, MD, MPH HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance
Implementation and expansion of high quality, sustainable and comprehensive HIV prevention, care, and treatment to achieve 90-90-90 goals in Western Kenya Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Health Systems Strengthening, Training International Scholars and Clinicians
HIV prevention in Mozambique Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS, Implementation and Behavioral Science
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Combination immune checkpoint blocker inhibition to eliminate HIV latency Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
GS-US-382-3961: A Phase 1b, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of GS-9620 in Antiretroviral Treated HIV-1 Infected Controllers Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Delaney AIDS Research Enterprise to Cure HIV Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Therapeutic vaccination and PD-1 blockade in treated HIV disease Steven Deeks, MD HIV/AIDS
Measuring the Latent reservoir for HIV Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Deeks Order CNICS: June 2014-Aug 2016 Steven Deeks, MD HIV/AIDS
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node Steven Deeks, MD HIV/AIDS
Programming Long Term Durable HIV-1 Specific T cell Responses Steven Deeks, MD HIV/AIDS, Immunology
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph Derisi, PhD Infectious Disease, Opportunistic Infection
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients Maria Ekstrand, PhD HIV/AIDS, Drug and Diagnostics Development, Treatment Adherence
Reducing AIDS stigma among health professionals in South India Maria Ekstrand, PhD HIV/AIDS, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Treatment Adherence
Improving Mental Health through Integration with Primary Care in Rural Karnataka Maria Ekstrand, PhD HIV/AIDS, Neurology and Mental Health, Stigma and Discrimination
International Medical Program for AIDS Clinical Training Mitchell Feldman, MD HIV/AIDS, Training International Scholars and Clinicians
Family Services Network - Ryan White HIV/AIDS Program Monica Gandhi, MD, MPH HIV/AIDS, Patient and Peer Education
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH HIV/AIDS, Women's Health, Newborn and Infant Health, Treatment Adherence
Hair Extensions;: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables Monica Gandhi, MD, MPH HIV/AIDS
Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare Monica Gandhi, MD, MPH HIV/AIDS
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP Monica Gandhi, MD, MPH HIV/AIDS, Women's Health, Treatment Adherence
Evaluation of Haiti Quality Improvement of HIV Care Elvin Geng, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Health Systems Strengthening
IeDEA Consortium East Africa data center Elvin Geng, MD, MPH HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
Work Order for CNICS Admin Core 5 Years (related to NIH R24 A1067039) Elvin Geng, MD, MPH HIV/AIDS, Epidemiology and Surveillance
R24 for the CFAR-Network for the Integrated Clinical Science, CNICS Elvin Geng, MD, MPH HIV/AIDS, Epidemiology and Surveillance
Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care Elvin Geng, MD, MPH HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT-R) Elvin Geng, MD, MPH HIV/AIDS, Engagement in Care, Treatment Adherence, Health Systems Strengthening
AIDS Education and Training Center, National Clinician Consultation Center Ronald Goldschmidt, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV, Hahn K24 Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse
Mobile technology to extend clinic-based counseling for HIV+s in Uganda Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients HIV/AIDS, Noncommunicable and/or Chronic Disease
Getting to Zero Coordinator/ SFPHF Diane Havlir, MD HIV/AIDS
Sustainable East Africa Research in Community Health (SEARCH) Diane Havlir, MD HIV/AIDS, Infectious Disease, Noncommunicable and/or Chronic Disease, Health Economics and Effectiveness, Access or Barriers to Care
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden Diane Havlir, MD HIV/AIDS, Tuberculosis
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane Havlir, MD HIV/AIDS, Cardiovascular Disease
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN) Diane Havlir, MD HIV/AIDS, Adolescent Health
Training in HIV Translational Research Diane Havlir, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
SFBay CTU Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Sustainable East Africa Research in Community Health Diane Havlir, MD HIV/AIDS, Epidemiology and Surveillance, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
ACTG, AIDS Clinical Trial Research Group Diane Havlir, MD HIV/AIDS, Opportunistic Infection
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) Diane Havlir, MD HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health
HIV epidemiology and public health Norman Hearst, MD, MPH HIV/AIDS, Epidemiology and Surveillance
Achieving durable retention in care for PMTCT Option B+: An intervention research Jaco Homsy, MD, MPH HIV/AIDS, Women's Health, Pediatrics, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis HIV/AIDS, Cardiovascular Disease
Effect of low dose methotrexate on endothelial function and inflammation in HIV HIV/AIDS, Cardiovascular Disease
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans HIV/AIDS, Cardiovascular Disease
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases Laurence Huang, MD HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease
Evaluating a community-driven cervical cancer prevention model in western Kenya Megan Huchko, MD HIV/AIDS, Cancer/Oncology, Women's Health
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV Peter Hunt, MD HIV/AIDS, Immunology
Intestinal MAIT Cells in HIV Infection Peter Hunt, MD HIV/AIDS
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter Hunt, MD Infectious Disease, HIV/AIDS, Tuberculosis
Investigating Mechanisms of HIV Persistence in the Gut Peter Hunt, MD HIV/AIDS, Immunology
Determinants of Functional Immune Defects in Treated HIV Infection and Aging Peter Hunt, MD HIV/AIDS, Aging
RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations Vivek Jain, MD HIV/AIDS, Drug and Diagnostics Development
Implementation science research on ART delivery in resource limited settings Vivek Jain, MD HIV/AIDS, Implementation and Behavioral Science
AIDS Malignancy Consortium (AMC) Lawrence Kaplan, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Pilot of Culturally Tailored Mpowerment for HIV Prevention Among YMSM in Beirut Susan Kegeles, PhD HIV/AIDS, Adolescent Health, Access or Barriers to Care, Risk Reduction and Prevention, Patient and Peer Education
HIV Prevention and Care for Peruvian MSM and Transgender Women Susan Kegeles, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Sexually Transmitted Infections (STIs), HIV/AIDS
Peer Navigation to Improve Engagement in Care for HIV-Positive MSM in South Africa Timothy Lane, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care, Patient and Peer Education
Innovation Challenge CDC Sheri Lippman, PhD, MPH HIV/AIDS
Activating Treatment as Prevention through Community Mobilization in South Africa Sheri Lippman, PhD, MPH HIV/AIDS, Engagement in Care, Risk Reduction and Prevention
Improving Health Outcomes for Women Living with HIV Sheri Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care
Multilevel mechanisms of HIV acquisition in young South African women Sheri Lippman, PhD, MPH HIV/AIDS, Women's Health, Access or Barriers to Care, Implementation and Behavioral Science
Does Shifting Gender Norms on the Community Level Lead to Increased HIV Services Uptake? Sheri Lippman, PhD, MPH HIV/AIDS, Stigma and Discrimination, Patient and Peer Education
M14-730 (EXPEDITION-2): A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
GSK_201585: Phase III, randomized, multicenter, parallel-group, non inferiority, open-label study evaluating the efficacy, safety, & tolerability of switching to long-acting cabotegravir plus long acting rilpivirine from current INI,NNRTI, or PI-based ART Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Epidemiological studies among drug users in Iran Mohsen Malekinejad, MD, DrPH HIV/AIDS, Epidemiology and Surveillance, Substance Abuse
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development
East Africa IEDEA Regional Consortium Jeffrey Martin, MD, MPH HIV/AIDS
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH HIV/AIDS
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer Jeffrey Martin, MD, MPH HIV/AIDS, Opportunistic Infection, Cancer/Oncology
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya Toby Maurer, MD HIV/AIDS, Cancer/Oncology
The impact of TB co-infection on the reservoir of persistent HIV in vivo Mike McCune, MD, PhD HIV/AIDS, Tuberculosis, Immunology
Timing of ART and homeostasis of the persistent HIV reservoir in the adult Mike McCune, MD, PhD HIV/AIDS, Immunology
Early Antiretroviral Therapy and HIV Remission in Perinatal Infection Mike McCune, MD, PhD HIV/AIDS
Research training in HIV-related transfusion medicine and hematology in South Africa Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Health Systems Strengthening, Training and Capacity Building
TO#2 Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance, Training and Capacity Building
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
Sputum Transcriptomic Expression Profiling in Study 31: Express 31 Payam Nahid, MD, MPH HIV/AIDS, Tuberculosis
Conduct a systematic review of interventions to improve adherence and retention during TB and HIV co-treatment among people living with HIV Payam Nahid, MD, MPH HIV/AIDS, Tuberculosis, Systematic Reviews and Guideline Development, Treatment Adherence
Minority Populations Prevention Researcher Training Torsten Neilands, PhD HIV/AIDS, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Next Generation of HPV and Cervical Cancer Research in HIV+ Women Joel Palefsky, MD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Marion Peters, MD HIV/AIDS, Infectious Disease
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants Marion Peters, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
HIV/AIDS Primary Care Capacity in Nursing (PCC) Carmen Portillo, RN, PhD, FAAN HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Richard Price, MD HIV/AIDS
I-TECH UCSF International AETC E. Michael Reyes, MD, MPH HIV/AIDS, Training and Capacity Building
The Ryan White HIV/AIDS Program Technical Assistance Resources, Guidance, Education, and Training (TARGET) Center: Online Technical Assistance Community E. Michael Reyes, MD, MPH HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
AIDS Education and Training Center E. Michael Reyes, MD, MPH HIV/AIDS, Patient and Peer Education
Protocol Development Co-Chair for Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of GSK 1349572, a novel integrase inhibitor, in combination regimens in HIV-1 Infected Infants, Children & Adolescents Theodore Ruel, MD HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics, Adolescent Health
LOC-IMPAACT Leadership Group Theodore Ruel, MD HIV/AIDS, Pediatrics, Newborn and Infant Health, Adolescent Health
Uganda METS M&E (Activity A) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
International Traineeships in AIDS Prevention Studies (ITAPS) George Rutherford, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Uganda METS CBS (Activity C) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President's Emergency Plan for AIDS Relief (PEPFAR) George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) George Rutherford, MD HIV/AIDS, Tuberculosis
UCSF-GSI Technical Assistance in Strategic Information and Health Systems Strengthening under NAM-PHACTS (Program Area C: Strategic Information Activities) George Rutherford, MD HIV/AIDS, Policy and Standards of Care, Epidemiology and Surveillance, Health Systems Strengthening
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care and Treatment Services throughout the Health System in South Africa George Rutherford, MD HIV/AIDS, Tuberculosis, Engagement in Care, Treatment Adherence
Enhancing Strategic Information Capacity for HIV/AIDS Programs in Kenya through Surveillance and Epidemiology and Monitoring and Evaluation under the U.S. PEPFAR (Program Areas A & B) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Training and Capacity Building, Training International Scholars and Clinicians
HIV Measurement, Surveillance & Evaluation Methods Consortium George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Recent Infection Surveillance Consortium George Rutherford, MD HIV/AIDS, Tuberculosis
A Mobile Health Application for Engagement in Care among Youth Living with HIV Parya Saberi, PharmD HIV/AIDS, Distance learning and mentoring
Disease susceptibility and global distribution of genetic variation Mark Seielstad, PhD HIV/AIDS, Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance
Sheroes Community-Based Research Programs, Center of Excellence for Transgender Health - Girlfriends Connect Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care
A couples-based approach to HIV prevention for transgender women and their male partners Jae Sevelius, PhD HIV/AIDS, Risk Reduction and Prevention
Mapping perceptions of PrEP use in transwomen and barriers to care in providers to inform intervention development Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care
Culturally relevant PrEP demonstration for trans communities Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Strengthening Mozambican Capacity in Strategic Information Systems under the President's Emergency Plan for AIDS Relief Starley Shade, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Global Strategic Information, Training and Capacity Building, Training International Scholars and Clinicians
International Maternal Pediatric Adolescent AIDS Clinical Trial Group Master Member Agreement HIV/AIDS, Women's Health, Newborn and Infant Health, Adolescent Health
Reproductive Tract Effects of the Intrauterine Device: Implications for HIV Risk HIV/AIDS, Family Planning
International Clinical Research Fellowship Christopher Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
HIV, HCV, and gender effects on Liver, Bone, and Vascular Health Phyllis Tien, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women Phyllis Tien, MD Infectious Disease, HIV/AIDS, Immunology, Women's Health
In Our Own Words: Peer-to-Peer Messaging to Increase Uptake of HIV Prevention Strategies among Adolescents in Kenya Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Adolescent Health, Engagement in Care
In Our Own Words: Peer-to-Peer Messaging to Increase Uptake of HIV Prevention Strategies among Adolescents in Kenya Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Adolescent Health, Engagement in Care
Role of HIV in acceleration of HPV malignancy Sharof Tugizov, PhD HIV/AIDS, Sexually Transmitted Infections (STIs), Cancer/Oncology
Role of oral herpesvirus microbiota in pathogenesis of HIV mother to child transmission Sharof Tugizov, PhD HIV/AIDS, Labor and Delivery, Newborn and Infant Health
Interventions for Symptom Management in Older Patients with HAND Victor Valcour, MD, PhD HIV/AIDS, Dementia and Cognitive Impairment
U.S. Army Medical Research Acquisition Activity (USAMRAA) Victor Valcour, MD, PhD HIV/AIDS, Neurology and Mental Health
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition Victor Valcour, MD, PhD HIV/AIDS, Aging
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60 Victor Valcour, MD, PhD HIV/AIDS, Neurology and Mental Health
DOT (Directly observed therapy) Diary Eric Vittinghoff, PhD HIV/AIDS, Tuberculosis
amfAR Institute for HIV Cure Research Paul Volberding, MD HIV/AIDS, Drug and Diagnostics Development
Recent Advances in AIDS and HIV Research Paul Volberding, MD HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
UCSF-Gladstone Center for AIDS Research Paul Volberding, MD HIV/AIDS, Neurology and Mental Health, Access or Barriers to Care, Stigma and Discrimination, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
Development of a UCSF-Gladstone CFAR Health Disparities Core Paul Volberding, MD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Assessing the preliminary effects of a multisectoral agricultural intervention on the sexual and reproductive health of HIV-affected adolescent girls Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Adolescent Health
Mechanisms and longitudinal effects of HIV-related stigma on women's adherence and outcomes Sheri Weiser, MD HIV/AIDS, Women's Health, Implementation and Behavioral Science, Treatment Adherence
Mentoring in Patient Oriented Research on Food Insecurity, HIV and Aging, Weiser K24 Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity
Implementation science and reproductive health on sub-Saharan Africa Joelle Brown, PhD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health, Labor and Delivery, Family Planning
Impact and Cost-effectiveness of Safer Conception Strategies for HIV Prevention Joelle Brown, PhD HIV/AIDS, Family Planning
Optimizing HIV counseling testing and referral through an adaptive drug use intervention HIV/AIDS, Engagement in Care
Substance Abuse and HIV/AIDS Prevention Services for At-Risk, Homeless Youth HIV/AIDS, Adolescent Health, Engagement in Care, Substance Abuse, Treatment Adherence
Offering Women with PrEP with Education, shared decision-making and trauma-informed care: the OPENS trial Christine Dehlendorf, MD, MAS HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence, Health Systems Strengthening
Advancing HIV Prevention and Substance Abuse Prevention: HIV Testing Program James Dilley, MD HIV/AIDS
STI Screening as a Combined HIV Prevention Platform for MSM in Peru James Dilley, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Engagement in Care
Trainings for HIV and HCV testing and prevention James Dilley, MD Infectious Disease, HIV/AIDS, Training and Capacity Building
Randomized Trial of Web-Based Support for Evidenced-Based HIV Prevention (PCC) James Dilley, MD HIV/AIDS
PrEP Navigators Services James Dilley, MD HIV/AIDS, Engagement in Care, Treatment Adherence
Statistical methods for clinical trials of novel PrEP agents David Glidden, PhD HIV/AIDS, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development
Translational evaluation of Aging, Inflammation, and HIV in Lung Dysfunction Ruth Greenblatt, MD HIV/AIDS, Chronic Respiratory Disease, Aging
Exploiting Genomic or Nucleomic Information to Understand HIV Latency in Individuals with Substance Use Disorders Ruth Greenblatt, MD HIV/AIDS, Genetics, Substance Abuse
Host Genetics of HIV: Enhancing Discovery through Study Design and New Tools Ruth Greenblatt, MD HIV/AIDS, Genetics
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Center of Excellence HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention, UCSF Professional Education, Patient and Peer Education
Ward 86 Outpatient Services / Perinatal Services HIV/AIDS, Women's Health, Newborn and Infant Health
African American Center of Excellence HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care, Health Systems Strengthening, Patient and Peer Education
Expanded HIV Testing for Disproportionately Affected Population HIV/AIDS
Women's Center of Excellence HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Patient and Peer Education
Consultation with the SFDPH HIV/AIDS surveillance unit Nancy Hessol, MSPH HIV/AIDS
UCSF Prevention Research Center Marguerita Lightfoot, PhD HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention, Patient and Peer Education
Substance Use and HIV Prevention Research in Minority Communities Training Program Marguerita Lightfoot, PhD HIV/AIDS, Substance Abuse
A Comprehensive Community-based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth At HIV Risk, Acutely Infected and with Established HIV Infection Marguerita Lightfoot, PhD HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
Center for AIDS Prevention Studies Marguerita Lightfoot, PhD HIV/AIDS, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Social Media Messaging for HIV Testing in Zimbabwe Marguerita Lightfoot, PhD HIV/AIDS, Access or Barriers to Care, Engagement in Care
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Coordinating Center Marguerita Lightfoot, PhD HIV/AIDS
Implementation science, and behavioral interventions in support of HIV prevention Christina (Krysia) Lindan, MD, MSc HIV/AIDS, Implementation and Behavioral Science
Social Media Evaluation and Technical Assistance Center HIV/AIDS
Using Evidence Informed Interventions to Improve Health Outcomes among People Living with HIV Evaluation HIV/AIDS
AIDS Education and Training Centers (AETC) National Evaluation Center (NEC) HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
Public Health Conference Support for the 2019 UCSF National Transgender Health Summit HIV/AIDS, Stigma and Discrimination
Transgender Evaluation and Technical Assistance Center HIV/AIDS, Access or Barriers to Care
Mentoring patient-oriented research on the health consequences of polydrug use Elise Riley, PhD HIV/AIDS, Cardiovascular Disease, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Substance Abuse, Training and Capacity Building
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Infectious Disease, HIV/AIDS, Engagement in Care
Development of Rectal Enema As Microbicide (DREAM) Rada Savic, PhD HIV/AIDS, Pharmacology and Drug Treatment
AIDS Policy Research Center Wayne Steward, PhD, MPH HIV/AIDS, Policy and Standards of Care
System-level Workforce Capacity Building for Integrating HIV Primary Care in Community Healthcare Settings - Evaluation and Technical Assistance Center Wayne Steward, PhD, MPH HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Spurring Innovation in HIV Testing and Linkage: A Crowdsourcing Approach Chongyi Wei, DrPH HIV/AIDS, Engagement in Care
Population-based Screening and Brief Intervention in Primary Care: Health and Drinking Outcomes, Cost and Utilization Constance Weisner, DrPH HIV/AIDS, Substance Abuse
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease Sulggi Lee, MD HIV/AIDS, Substance Abuse
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling Sulggi Lee, MD HIV/AIDS, Immunology
HIV prevention among female sex workers in Kampala, Uganda Rachel King, PhD, MPH HIV/AIDS, Stigma and Discrimination, Risk Reduction and Prevention
Implementing computerized substance use and depression screening and evidence-based treatments in an HIV primary care population HIV/AIDS
2/3 COMpAAAS Tripartite: ART-CC, KP, and VA HIV/AIDS
The Impact of Health Care Reform on Addiction and HIV Services HIV/AIDS
Mentoring alcohol use intervention research in health care settings HIV/AIDS, Substance Abuse
Epidemiology capacity building Nancy Hills, PhD HIV/AIDS, Infectious Disease, Epidemiology and Surveillance
Single-cell trancriptomic analysis of HIV infected CD4 cells in blood and lymphoid tissue using PCR activated cell sorting Adam Abate, PhD HIV/AIDS
Role of proviral loci in HIV latency Adam Abate, PhD HIV/AIDS, Immunology
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis Felicia Chow, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Cerebrovascular mechanisms of HIV-associated cognitive impairment in China Felicia Chow, MD HIV/AIDS, Neurology and Mental Health
Elucidating the mechanism of macrophage death during infection with the AIDS-associated opportunistic pathogen Histoplasma capsulatum Anita Sil, MD, PhD HIV/AIDS, Opportunistic Infection
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Gender Based Violence and HIV Outcomes-Tracking and Treating Mental Illness Susan Meffert, MD, MPH HIV/AIDS, Neurology and Mental Health, Trauma and PTSD, Women's Health
Point-of-care C-reactive protein-based tuberculosis screening among people living with HIV: planning a comparative effectiveness trial Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis
Evaluation of Novel Tuberculosis Screening Strategies for People living with HIV Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis
Individual, social, and structural factors on disease transmission in marginalized populations Meghan Morris, PhD, MPH HIV/AIDS, Infectious Disease, Access or Barriers to Care
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
Award - Development of a Social Network-enhanced Adherence Intervention for PrEP in Young African Women Catherine Koss, MD HIV/AIDS, Treatment Adherence
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD HIV/AIDS, Tuberculosis, Pediatrics, Epidemiology and Surveillance
Health, Empowerment, and Recovery Services (HERS) Program Edward Machtinger, MD HIV/AIDS, Substance Abuse
Using Information to Align Services and Link and Retain Men in the HIV Cascade Shari L. Dworkin, PhD, MS HIV/AIDS, Engagement in Care, Patient and Peer Education
Defining the clinical utility of CSF biomarkers of neurodegeneration in HIV+ elders HIV/AIDS, Neurology and Mental Health
Relationship Factors and Engagement in HIV Care in Malawi: A Dyadic Investigation Amy Conroy, PhD HIV/AIDS, Access or Barriers to Care, Implementation and Behavioral Science, Engagement in Care
Single Cell Characterization of Latent HIV-1 Reservoirs HIV/AIDS, Immunology
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin HIV/AIDS, Immunology
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics HIV/AIDS, Drug and Diagnostics Development
HIV Cures - Paving the way towards elimination of HIV persistent CD4 T cell in vivo HIV/AIDS, Immunology
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells HIV/AIDS, Drug and Diagnostics Development
Reaching Adolescent Girls and Young Women through Girl-friendly Drug Vendors Jenny Liu, PhD, MPP, MA HIV/AIDS, Family Planning, Adolescent Health, Access or Barriers to Care
Reaching 90 90 90 in Adolescents in Zambia: Using all our SKILLZ Jenny Liu, PhD, MPP, MA HIV/AIDS, Women's Health, Adolescent Health
Identifying barriers to diabetes and HIV co-management in vulnerable populations Kartika Palar, PhD HIV/AIDS, Diabetes, Women's Health
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
Director of TREAT Asia and VP of Global Initiatives for amfAR Annette Sohn, MD HIV/AIDS, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Dating Violence Prevention for Juvenile Justice Girls HIV/AIDS, Adolescent Health, Patient and Peer Education
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS HIV/AIDS, Sexually Transmitted Infections (STIs), Access or Barriers to Care, Stigma and Discrimination
Blood safety standards and lab capacity in low & mid income countries Elizabeth Donegan, MD HIV/AIDS, Infectious Disease, Transfusion Medicine, Training International Scholars and Clinicians, Distance learning and mentoring
HIV epidemiology among vulnerable populations in Iran Ali Mirzazadeh, PhD, MD, MPH HIV/AIDS, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Policy and Standards of Care, Epidemiology and Surveillance
Population Size Estimation and Mapping of Three Key Populations in Seven Cities in Afghanistan in 2018 Ali Mirzazadeh, PhD, MD, MPH HIV/AIDS, Epidemiology and Surveillance
Improving engagement in care via Community-based mHealth Motivational Interviewing Tool for HIV-positive youth (COMMIT+) Bibhav Acharya, MD HIV/AIDS, Training and Capacity Building, Training International Scholars and Clinicians, Patient and Peer Education
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia Steven Stoltz, MD Opportunistic Infection, Chronic Respiratory Disease
The Better THAN Study: Targeting Heavy Alcohol with Naltrexone among MSM Glenn-Milo Santos, PhD, MPH HIV/AIDS, Implementation and Behavioral Science, Substance Abuse
Long distance mentoring in global oncology Anu Agrawal, MD HIV/AIDS, Cancer/Oncology
Global Strategies for HIV Prevention Arthur Ammann, MD HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Access or Barriers to Care
Transfusion science and HIV, HTLV, and dengue research in Brazil Philip Norris, MD Infectious Disease, HIV/AIDS, Immunology, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium Robert Owen, MD Opportunistic Infection, Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
HIV Global Strategic Information Education and Training in Kenya Sandy Schwarcz, MD, MPH HIV/AIDS
Burkitt’s lymphoma and Kaposi’s sarcoma in Uganda John Ziegler, MD, MSc Infectious Disease, HIV/AIDS
Deputy Director of the International Traineeships in AIDS Prevention Studies (ITAPS) Debbie Brickley, DrPH, MPH HIV/AIDS, Epidemiology and Surveillance, Training International Scholars and Clinicians
HIV surveillance, data analysis, and data use Michael Grasso, MPH HIV/AIDS, Epidemiology and Surveillance
Engagement in Clinical Care for HIV-Infected Individuals Leaving Jail Kim Koester, PhD HIV/AIDS
Mental health and HIV in adolescents in Malawi Susan Kools, RN, PhD HIV/AIDS, Neurology and Mental Health, Adolescent Health
Social determinants and consequences of household food insecurity among persons living with HIV/AIDS Jason Nagata, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Adolescent Health
Systematic reviews of qualitative and quantitative data on global health topics Jason Nagata, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Implementation and Behavioral Science
Assessing climate change awareness and climate-adaptive agricultural strategies in Shamba Maisha, an integrated HIV-care and agricultural livelihood intervention to improve nutrition and health in Western Kenya Tammy Nicastro, MS HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Patient and Peer Education
Clinical care and medical education David Sears, MD Infectious Disease, HIV/AIDS, Malaria
HIV bio-behavioral surveillance studies in Ghana and Mozambique Kelly Taylor, PhD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
Pre-exposure Prophylaxis for People Involved in Criminal Justice Systems Emily Dauria, MD, PhD HIV/AIDS, Adolescent Health, Access or Barriers to Care, Stigma and Discrimination
Integrated Community-based Treatment of HIV and Hypertension in Zambia Monika Roy, MD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Improving access to quality healthcare for people living with HIV Mary McQuilkin, BSN, RN, MSN, NP, MPH HIV/AIDS, Access or Barriers to Care, Immigration and Migration
Transportability of Causal Effects to Inform HIV Pre-exposure Prophylaxis Implementation Megha L. Mehrotra, MPH HIV/AIDS, Epidemiology and Surveillance
Development of a Couple-Based Mobile Health Intervention for Enhancing HIV Care Engagement Outcomes HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Postpartum Adherence to HIV treatment and Prevention of Mother to Child Transmission Strategies: The Implications of Transitions Among Women Living with HIV in Kisumu County, Kenya Emily L. Tuthill, PhD HIV/AIDS, Newborn and Infant Health, Treatment Adherence
Understanding the role of food insecurity and depression in non-adherence to Option B+ among perinatal Kenyan women living with HIV: a Syndemics approach Emily L. Tuthill, PhD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Neurology and Mental Health, Women's Health, Newborn and Infant Health, Treatment Adherence
Family Composition and Mental Health: Promoting ART Adherence in the Age of UNAIDS 90-90-90 Target Lynhea Anicete, BS, BA HIV/AIDS, Treatment Adherence
Understanding Patient Preferences for HIV Care and Treatment in San Francisco: Evidence from a Discrete Choice Experiment Madellena Conte, BA HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
Understanding the Risk of HIV/AIDS in Ugandan Female Sex Workers Nardos Darkera, BS HIV/AIDS, Occupational and Environmental Disease
HIV/Drug Abuse Prevention Research Ethics Training Institute John A. Sauceda, MD HIV/AIDS, Access or Barriers to Care, Engagement in Care, Treatment Adherence
An adaptive treatment intervention for depression and engagement in HIV care among Latinos living with HIV John A. Sauceda, MD HIV/AIDS, Neurology and Mental Health
Technical Assistance for Quality Management Capacity Building in Haiti Bruce D. Agins, MD, MPH HIV/AIDS, Implementation and Behavioral Science
A Formative Assessment of the Continuum of Care Needs of HIV-Positive Men who Have Sex with Men in Ghana Akua Gyamerah, DrPH, MPH HIV/AIDS, Engagement in Care, Treatment Adherence
Engagement and retention in tuberculosis care services among people living with HIV in Lusaka, Zambia: does gender matter?​ Andrew Kerkhoff, MD, PhD HIV/AIDS, Tuberculosis, Stigma and Discrimination, Engagement in Care, Treatment Adherence

Active Projects: 1009

Project Investigator
All Topics Start date End date
HIV testing and HIV surveillance HIV/AIDS, Epidemiology and Surveillance
Blood Donation and HIV Prevention in China Vincanne Adams, PhD HIV/AIDS
Dissertation Research: Resistant to Treatment: Medicine, Molecules, and the Global Politics of Drug-Resistant HIV Vincanne Adams, PhD HIV/AIDS
Recombinant Picornaviruses as AIDS Vaccines Raul Andino-Pavlovsky, PhD HIV/AIDS
Vaccine to Prevent HIV Infection in Pregnancy and Newborns Raul Andino-Pavlovsky, PhD HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health
Adult AIDS Clinical Trials Group (AACTG): Pharmacology Support Laboratory Francesca Aweeka, PharmD HIV/AIDS
Testing Sponsor's Antiretroviral Enzyme Immunoassay Method Francesca Aweeka, PharmD HIV/AIDS
ACTG: AIDS Clinical Trials Group; MASTER SUBCONTRACT -- U01AI068636 Francesca Aweeka, PharmD HIV/AIDS
Pediatric AIDS Clinical Trial Group (PACTG) Pharmacology Support Laboratories Francesca Aweeka, PharmD HIV/AIDS
IMPAACT: International Maternal Pediatrics Adolescent AIDS Clinic Francesca Aweeka, PharmD HIV/AIDS, Women's Health, Pediatrics
DDI study between HIV drugs (Efavirenz) and Coartem Francesca Aweeka, PharmD HIV/AIDS
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Leadership Award Francesca Aweeka, PharmD HIV/AIDS, Pediatrics
T001: Adult AIDS Clinical Trials Group (AACTG): Pharmacology Laboratory Francesca Aweeka, PharmD HIV/AIDS
LOC-IMPAACT Leadership Group Francesca Aweeka, PharmD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development
T003: International Maternal Pediatric Adolescent AIDS Clinical Trials Group IMPAACT Francesca Aweeka, PharmD HIV/AIDS, Women's Health, Pediatrics
Pharmacokinetic analysis of dihydroartemisinin-piperaquine alongside the START-IPT Study Francesca Aweeka, PharmD HIV/AIDS, Malaria, Pediatrics
Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda Francesca Aweeka, PharmD HIV/AIDS, Malaria, Women's Health, Pediatrics
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Francesca Aweeka, PharmD HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health
2.1 Project Title ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD Infectious Disease, HIV/AIDS, Tuberculosis
AIDS Clinical Trials Group Network Francesca Aweeka, PharmD HIV/AIDS
International Maternal Pediatrics Adolescent AIDS Clinic (IMPAACT) Francesca Aweeka, PharmD HIV/AIDS, Malaria, Women's Health, Pediatrics
Regulatory Circuits That Link Cell Fate and Virulence in Histoplasma Capsulatum Opportunistic Infection
HIV/STD Prevention Among Angolan Military HIV/AIDS, Risk Reduction and Prevention, Patient and Peer Education
Adolescent Medicine Trials Network for HIV/AIDS HIV/AIDS, Adolescent Health
Technical and Logistical Support for the Office of AIDS Research HIV/AIDS
Leadership Group for the Adolescent Medicine Trials Network HIV/AIDS, Adolescent Health
An Innovative HIV Prevention Curriculum for Medical Students of the University of Puerto Rico Medical School: Implementation and Evaluation Phase HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Identifying Opportunities for HIV Prevention among Female Migrants in Kenya Carol Camlin, PhD HIV/AIDS, Women's Health, Immigration and Migration, Risk Reduction and Prevention
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
Prevention Umbrella for MSM in the Americas Henry Chambers, MD HIV/AIDS
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Henry Chambers, MD HIV/AIDS, Opportunistic Infection
Prevention Umbrella for MSM in the Americas Henry Chambers, MD HIV/AIDS, Risk Reduction and Prevention
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Epidemiologic Analysis of Data from Project Aware to Determine the Impact of Different HIV Testing Strategies on Risk Behaviors and STD Rates among HIV-Uninfected MSM Henry Chambers, MD HIV/AIDS
Phase III Study: Safety & Efficacy of Daptomycin Compared to Conventional Therapy in the Treatment of Subjects w/ infective endocarditis or bacteremia due to Staphylococcus aureus Henry Chambers, MD Opportunistic Infection
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD HIV/AIDS, Tuberculosis, Epidemiology and Surveillance
Innovative incentive strategies for sustainable HIV testing and linkage to care Gabriel Chamie, MD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Novel Evaluation Methods for Multi-Level/Combination HIV Prevention Interventions Edwin Charlebois, PhD HIV/AIDS
Getting to Zero: Advancing Retention and Re-Engagement in HIV Care Demonstration Project Edwin Charlebois, PhD HIV/AIDS, Engagement in Care, Treatment Adherence
Structural Alcohol/HIV Risk Intervention in Gay Bar Patrons Edwin Charlebois, PhD HIV/AIDS, Risk Reduction and Prevention
Structural Alcohol/HIV RIsk Intervention in Gay Bar Patrons Edwin Charlebois, PhD HIV/AIDS
Enhancing Care Engagement and Re-engagement Edwin Charlebois, PhD HIV/AIDS, Engagement in Care, Treatment Adherence
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis Edwin Charlebois, PhD HIV/AIDS, Tuberculosis, Implementation and Behavioral Science
Structural Alcohol Intervention to Reduce HIV Risk Behavior among Gay Bar Patrons Edwin Charlebois, PhD HIV/AIDS
HVTN 703/HPTN 081 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
HVTN 107 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG HIV/AIDS
HPTN 081 Protocol Funding - Development Costs Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Risk Reduction and Prevention
University of Zimbabwe-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Health Systems Strengthening, Training and Capacity Building
St Marys - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
The Bixby Center for Global Reproductive Health - Annual Research Day Conference Zvavahera Chirenje, MD, FRCOG HIV/AIDS
UZ-UCSF CTU JHU IMPAACT PF: Task Order 3 Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health
Seke North - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
HPTN 084 Development Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS
UZ-UCSF CTU Parirenyatwa Clinical Research Site HPTN 052 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Family Planning
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
Integrating HIV/STI Prevention/Treatment in China Kyung-Hee Choi, MPH, PhD HIV/AIDS
An HIV Prevalence and Risk Behavior Survey of Male Sex Workers in Shanghai, China Kyung-Hee Choi, MPH, PhD HIV/AIDS
Developing a Network-based HIV Prevention Intervention for MSM in China [II] Kyung-Hee Choi, MPH, PhD HIV/AIDS
Influence of Stigma and Discrimination on HIV Risk among Men in China Kyung-Hee Choi, MPH, PhD HIV/AIDS, Risk Reduction and Prevention
Social/Sexual Networks & HIV Risk: Men of Color Kyung-Hee Choi, MPH, PhD HIV/AIDS
Developing a Network-based HIV Prevention Intervention for MSM in China [I] Kyung-Hee Choi, MPH, PhD HIV/AIDS
Developing an HIV Prevention Intervention for HIV-Positive Men in China Kyung-Hee Choi, MPH, PhD HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention
Optimizing Rapid and Full Engagement in Care for Persons with Newly Diagnosed HIV HIV/AIDS, Engagement in Care
The Medical Consequences of Different Types of Heroin Daniel Ciccarone, MD, MPH Infectious Disease, HIV/AIDS, Substance Abuse
HIV-HEP C Website Maintenance Services Susan Coffey, MD Infectious Disease, HIV/AIDS, Patient and Peer Education
AETC National Resource Center / AIDS Education and Training Website Susan Coffey, MD HIV/AIDS, Training and Capacity Building
VA HIV Website Susan Coffey, MD HIV/AIDS
Adolescent Modules - AETC Web Site Susan Coffey, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Adolescent Modules - AETC Web Site (Cont.) Susan Coffey, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Women, Children, and HIV Website (DBS) Susan Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
Women, Children, and HIV Website Susan Coffey, MD HIV/AIDS, Women's Health, Patient and Peer Education
UMDNJ / WHO Dept. of HIV/AIDS "Development of an Annotated Inventory of PMTCT Tools and Guidelines" Susan Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
UMDNJ / "Tanzania PMTCT Training Package" Susan Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Training and Capacity Building
VA HIV-HEP C Website Maintenance Services Susan Coffey, MD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Patient and Peer Education
National Resource Center for HIV/AIDS Prevention among Adolescents (APNRC) Susan Coffey, MD HIV/AIDS
AIDS Education and Training Center (AETC) National Resource Center / Website Susan Coffey, MD HIV/AIDS, Opportunistic Infection, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
Women, Children, and HIV Website Susan Coffey, MD HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Training and Capacity Building
Pilot Agricultural Intervention for Food Security and HIV Outcomes in Kenya Craig Cohen, MD, MPH HIV/AIDS
Phase III Randomized , Placebo-Controlled Trial of HSV-2 Supression to Prevent HIV Transmission Among HIV Discordant Couples HSV-2/HIV Transmission Study Craig Cohen, MD, MPH HIV/AIDS
Stakeholder Meeting on the Integration of Reproductive Health and HIV/AIDS Craig Cohen, MD, MPH HIV/AIDS, Women's Health
HIV Treatment for Research Subjects or By Researchers in Kenya Craig Cohen, MD, MPH HIV/AIDS
Integrating Family Planning into HIV Care and Treatment Craig Cohen, MD, MPH HIV/AIDS
Process Evaluation and Toolkit Development in Support of Family Planning Integration into HIV Care & Treatment in Kenya Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Family Planning, Newborn and Infant Health, Adolescent Health, Engagement in Care, Health Systems Strengthening
Impact of ART on Sexual Behaviors in Kisumu, Kenya Craig Cohen, MD, MPH HIV/AIDS
STAR STI CTG Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Travel Scholarships for Integration of Reproductive Health and HIV/AIDS Services Conference Craig Cohen, MD, MPH HIV/AIDS
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
(PrEP) Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV1 Acquisition within HIV1 Discordant Couples Craig Cohen, MD, MPH HIV/AIDS
HIV/HSV Study Completion Craig Cohen, MD, MPH HIV/AIDS
Integration of Family Planning into HIV Care and Treatment in Nyanza Province, Kenya Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Supporting the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in Kenya under PEPFAR Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Integrating Family Planning Services into HIV Care and Treatment in Nyanza Province, Kenya - Phase II Craig Cohen, MD, MPH HIV/AIDS
Consequences of an Intervention to Promote the Pasteurization of Breastmilk to Reduce the Transmission of HIV from Mothers to Their Breastfed Infants Craig Cohen, MD, MPH HIV/AIDS
Accelerating Children's HIV/AIDS Treatment (ACT) initiative Craig Cohen, MD, MPH HIV/AIDS, Pediatrics, Access or Barriers to Care, Health Systems Strengthening, Training and Capacity Building
HIV Shedding from the Female Genital Tract Craig Cohen, MD, MPH HIV/AIDS, Women's Health
Development of a Live Topical Microbicide for Women Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Risk Reduction and Prevention
Secretion of Virulence Factors by Mycobacterium tuberculosis Infectious Disease, HIV/AIDS, Tuberculosis, Genetics
New Challenges in HIV Prevention for Gay Male Couples Lynae Darbes, PhD HIV/AIDS
HIV prevention for male couples in Africa Lynae Darbes, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Risk Reduction and Prevention
Couples-Based HIV Prevention in South Africa Lynae Darbes, PhD HIV/AIDS
Implementing Partner: Understanding the HIV prevention needs of men who have sex with men (MSM) and their partners in Southern Africa: KwaZulu-Natal, South Africa and Namibia Lynae Darbes, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Patient and Peer Education
A Home-Based Couples Intervention to Enhance Prevention of Mother-to-Child-Transmission (PMTCT) and Family Health in Kenya Lynae Darbes, PhD HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence
Couples in Context: A Random Control Trial (RCT) of a Couples-Based HIV Prevention Lynae Darbes, PhD HIV/AIDS, Risk Reduction and Prevention
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans HIV/AIDS
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans HIV/AIDS
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Prevention with Positives Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Combination HIV Prevention for the General Population of Adults and Youth, including Persons Living with HIV in Mozambique Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS, Implementation and Behavioral Science
Prevention for HIV-Positive Persons: An Intervention for HIV Care Providers Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
DARE: Delaney AIDS Research Enterprise to Find a Cure Steven Deeks, MD HIV/AIDS
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Atripla Adherence and Resistance Relationships [II] Steven Deeks, MD HIV/AIDS, Treatment Adherence
HIV Controllers: A Potential Model for HIV Eradication Steven Deeks, MD HIV/AIDS, Immunology
San Francisco National Clinical Trial Center, ESPIRIT Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven Deeks, MD HIV/AIDS
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir Steven Deeks, MD HIV/AIDS
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research Steven Deeks, MD HIV/AIDS
T Regulatory Cells and T Cell Activation in HIV Disease Steven Deeks, MD HIV/AIDS, Immunology
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT Steven Deeks, MD HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Steven Deeks, MD HIV/AIDS
UCSF/Ragon Collaboration on HIV "Elite" Controllers Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development, Immunology, Genetics
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response Steven Deeks, MD HIV/AIDS, Immunology
Atripla Adherence and Resistance Relationships [I] Steven Deeks, MD HIV/AIDS, Treatment Adherence
Treatment Intensification for Drug-Resistant HIV Steven Deeks, MD HIV/AIDS
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients Steven Deeks, MD HIV/AIDS
Characterizing the Role of Immune Activation in HIV Persistence Steven Deeks, MD HIV/AIDS, Immunology
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV Entry Inhibitors: A New Therapeutic Option Steven Deeks, MD HIV/AIDS, Immunology
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven Deeks, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Enhancing Control of HIV by Inhibiting TRAIL Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation Steven Deeks, MD HIV/AIDS
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven Deeks, MD HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Identifying and Targeting HIV Persistence in T Cell Subsets during ART Steven Deeks, MD HIV/AIDS
HIV Specific T-Cell Responses in Rectal Mucosa Steven Deeks, MD HIV/AIDS
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven Deeks, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Pharmacology and Drug Treatment
Innate Effector Function and HIV-1 Control Steven Deeks, MD HIV/AIDS, Immunology
Impact of HIV-Associated Inflammation on Disease Steven Deeks, MD HIV/AIDS
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients Steven Deeks, MD HIV/AIDS, Immunology, Women's Health
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation Steven Deeks, MD HIV/AIDS, Women's Health
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir Steven Deeks, MD HIV/AIDS, Immunology, Genetics
Epigenetic Regulation of HIV Latency Steven Deeks, MD HIV/AIDS
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease Steven Deeks, MD HIV/AIDS, Immunology
Treating HIV-infected Elite Controllers as a Model of HIV Remission Steven Deeks, MD HIV/AIDS
Elite Controllers Steven Deeks, MD HIV/AIDS, Immunology, Genetics
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD HIV/AIDS
Interactions Between HIV and Malaria in African Children Matthew Dorsey, MD HIV/AIDS, Malaria
Context and Correlates of Health Behaviors in South India Maria Ekstrand, PhD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Substance Abuse
Enhancing HIV Treatment Adherence in South India: The Chetana study Maria Ekstrand, PhD HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
AshaCare & Nutrition Program for Rural Indian Women Living with AIDS and Children Maria Ekstrand, PhD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Women's Health, Pediatrics
Examining ART Adherence Issues in Bangalore, India Maria Ekstrand, PhD HIV/AIDS, Treatment Adherence
Homeless Female Offenders Returning to the Community: Improving Hopeful Futures Maria Ekstrand, PhD HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence, Health Systems Strengthening
Reducing AIDS stigma among health professionals in South India Maria Ekstrand, PhD HIV/AIDS
Examining ART Adherence Issues in Bangalore, India Maria Ekstrand, PhD HIV/AIDS
Enhancing HIV treatment adherence in South India: The Chetana study Maria Ekstrand, PhD HIV/AIDS, Women's Health, Stigma and Discrimination, Implementation and Behavioral Science, Treatment Adherence
AshaCare and Nutrition Program for Rural Indian Women Living with AIDS and Children Maria Ekstrand, PhD HIV/AIDS, Women's Health
Asha HIV Health Promotion Intervention Maria Ekstrand, PhD HIV/AIDS
AIDS Stigma and Gender: Health Consequences in Urban India Maria Ekstrand, PhD HIV/AIDS
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV HIV/AIDS, Tuberculosis
Culture-Based Prediction of Adolescent HIV Risk Behavior HIV/AIDS, Adolescent Health, Risk Reduction and Prevention
Analysis of HIV-Specific Lymphocytes in Infants Using Single-Cell Microtools Margaret Feeney, MD HIV/AIDS
The Impact of CD8 T Cells on Viral Control and Evolution in HIV-Infected Infants Margaret Feeney, MD HIV/AIDS
The Immune Response to Acute Perinatal HIV Infection Margaret Feeney, MD HIV/AIDS
Japanese Health Professionals HIV/AIDS Training Program Mitchell Feldman, MD HIV/AIDS, Training International Scholars and Clinicians
HIV/AIDS Clinical Care Training Program for Japanese Physicians Mitchell Feldman, MD HIV/AIDS, Training and Capacity Building
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
Positive Health Access to Services and Treatment (PHAST) Monica Gandhi, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Hair measures to assess adherence and explain outcomes in an HIV clinical trial Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
AIDS Clinical Trials Group Monica Gandhi, MD, MPH HIV/AIDS
HIV Clinical Fellowship Monica Gandhi, MD, MPH HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH HIV/AIDS
Herpesviral Gene Expression in Kaposi's Sarcoma HIV/AIDS, Cancer/Oncology, Genetics
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa Elvin Geng, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
Evaluation of Haiti Quality Improvement of HIV Care Elvin Geng, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Quality Improvement Evaluation Center (Q-IEC) Elvin Geng, MD, MPH HIV/AIDS
Geng's work Order fee for Service Agreement / BMS MI A1424-562 Elvin Geng, MD, MPH HIV/AIDS
Geng Work Order RTI Health Solutions (Services for RTI/ViiV) Elvin Geng, MD, MPH HIV/AIDS
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Elvin Geng, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Engagement in Care
Tenofovir Kidney Toxicity Study HIV/AIDS, Pharmacology and Drug Treatment
National HIV Training and Technical Cooperative Agreements-Focus Area: HIV/AIDS Medical Homes Ronald Goldschmidt, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Training and Capacity Building
Monitoring and Evaluating the State Legislative/Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-care Settings Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development
National HIV/AIDS Clinicians' Consultation Center Ronald Goldschmidt, MD HIV/AIDS
Lutheran MC US-Caribbean HIV/AIDS Twinning Initiative Ronald Goldschmidt, MD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building
The New York PEPline Ronald Goldschmidt, MD HIV/AIDS, UCSF Professional Education, Patient and Peer Education
National HIV/AIDS Clinicians' Consultation Center Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building, UCSF Professional Education
UCSF - Ethiopia Fitun Warmline Ronald Goldschmidt, MD HIV/AIDS
AIDS Education and Training Center, Telehealth Training Centers Program Ronald Goldschmidt, MD HIV/AIDS
Monitoring and Evaluating the State Legislative /Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-Care Settings Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development
The New York Pepline Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Health Marketing Services for the CDC Act Against AIDS campaigns: HIV Screening Standard Care for Primary Care Physicians (HSSC) & One Test Two Lives (OTTL) for Obstetrical Providers Ronald Goldschmidt, MD HIV/AIDS
For the Sarlo Teaching Award of the UCSF AIDS Research Institute John Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
HIV-Related Oral Diseases Among Women in Harare John Greenspan, BDS, PhD HIV/AIDS, Women's Health
Sarlo Award for Excellence in Teaching for the AIDS Research Institute at UCSF John Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
Teaching in Excellence Award for the AIDS Research Institute John Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
Oral Manifestations of AIDS John Greenspan, BDS, PhD HIV/AIDS
HIV Voluntary Testing and Counseling (VCT) and Linkage to Care in Uganda Judith Hahn, PhD, MD HIV/AIDS
Changes in Alcohol Consumption in HIV Positives in Uganda Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Impact of Heavy Alcohol Use on Pre-ART HIV Disease -- Uganda ARCH Cohort Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Training in Research Program on Alcohol Use by Persons-with-or-at-Risk for HIV Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Integrating Alcohol Screening and Brief Intervention into HIV Care Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Measurement of Alcohol Use among HIV-Positives in Uganda Judith Hahn, PhD, MD HIV/AIDS
Regulatory T Cell Influence on Infant and Adult Immune Responses to HIV HIV/AIDS
Oral Drug Treatment for Enhanced Immune Control over HIV Replication HIV/AIDS, Pharmacology and Drug Treatment
Treating HIV-Infected Elite Controllers as a Model of HIV Remission HIV/AIDS
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients HIV/AIDS, Immunology
Virologic and Host Factors Contributing to HIV Control in Elite Controllers HIV/AIDS
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals HIV/AIDS, Cardiovascular Disease
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir HIV/AIDS
Treating HIV-Infected Elite Controllers as a Model of HIV Remission HIV/AIDS, Immunology
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study HIV/AIDS, Pharmacology and Drug Treatment
Reducing Failure-to-Initiate ART: Streamlined ART Start Diane Havlir, MD HIV/AIDS, Access or Barriers to Care, Implementation and Behavioral Science, Engagement in Care
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) Diane Havlir, MD HIV/AIDS
Training in HIV Translational Research Diane Havlir, MD HIV/AIDS, Training and Capacity Building
AIDS Research and Services at SFGH Diane Havlir, MD HIV/AIDS
Training in HIV Primary Care - Uganda Clinicians Diane Havlir, MD HIV/AIDS, Training and Capacity Building
UCSF HIV/AIDS Management Training Programs Diane Havlir, MD HIV/AIDS, Training and Capacity Building
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Diane Havlir, MD HIV/AIDS
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane Havlir, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health
UCSF HIV Clinical Trials Unit Diane Havlir, MD HIV/AIDS
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane Havlir, MD HIV/AIDS, Tuberculosis
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis
AIDS Clinical Trials Group (ACTG) TTSG Services Diane Havlir, MD HIV/AIDS
International AIDS Research and Prevention Diane Havlir, MD HIV/AIDS
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Diane Havlir, MD HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) Diane Havlir, MD HIV/AIDS, Malaria
Task Order Supplement to A5267 Diane Havlir, MD HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa Diane Havlir, MD HIV/AIDS, Malaria, Women's Health, Pediatrics
Clinical Studies of Interactions Between HIV and Malaria Diane Havlir, MD HIV/AIDS, Malaria
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Diane Havlir, MD HIV/AIDS
AIDS Clinical Trials Group (ACTG) Community Health Promoter Diane Havlir, MD HIV/AIDS
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load Diane Havlir, MD HIV/AIDS
Adult AIDS Clinical Trials Unit (AACTU) Diane Havlir, MD HIV/AIDS
AIDS Research and Services at SF General Hospital Diane Havlir, MD HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Diane Havlir, MD HIV/AIDS, Cardiovascular Disease
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis
Heals Endowment Fund at the East Bay Community Foundation Diane Havlir, MD HIV/AIDS
Therapeutic Strategies for HIV Disease Diane Havlir, MD HIV/AIDS
Therapeutic Strategies for HIV Disease Diane Havlir, MD HIV/AIDS
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Diane Havlir, MD HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes
Neurological AIDS Research Consortium Diane Havlir, MD HIV/AIDS
Task Order # 6: Supplement to SSS A5257 Diane Havlir, MD HIV/AIDS
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane Havlir, MD HIV/AIDS, Engagement in Care, Health Systems Strengthening, Training and Capacity Building
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) Diane Havlir, MD HIV/AIDS, Malaria
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Diane Havlir, MD HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis
Task Order # 7: Supplement to SSS A5254 Diane Havlir, MD HIV/AIDS, Opportunistic Infection, Oral Health
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Diane Havlir, MD HIV/AIDS
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane Havlir, MD HIV/AIDS, Pediatrics
SEARCH/AIDS Clinical Trial Research Group Diane Havlir, MD HIV/AIDS
Task Order # 9: Supplement to SSS A5272 Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
AIDS Clinical Trials Group; Protocol Funds Diane Havlir, MD HIV/AIDS
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) Diane Havlir, MD HIV/AIDS
Effect of Pitavastatin on Kidney Function in HIV-infected Persons Diane Havlir, MD HIV/AIDS, Cardiovascular Disease
Developing an International Research Program in AIDS and Substance Abuse [II] Norman Hearst, MD, MPH HIV/AIDS
Developing an International Research Program in AIDS and Substance Abuse Norman Hearst, MD, MPH HIV/AIDS, Substance Abuse
Developing an International Research Program in AIDS and Substance Abuse [I] Norman Hearst, MD, MPH HIV/AIDS, Engagement in Care, Health Systems Strengthening
Improving and Evaluating HIV Response Implementation Norman Hearst, MD, MPH HIV/AIDS, Health Economics and Effectiveness, Policy and Standards of Care
Posting at the Makerere University and Johns Hopkins University HIV Clinical Trials Unit in Kampala, Uganda Jaco Homsy, MD, MPH HIV/AIDS
Primary HIV Prevention in Pregnant and Lactating Ugandan Women Jaco Homsy, MD, MPH HIV/AIDS, Women's Health
HQHIV1003203 Philip Hopewell, MD HIV/AIDS, Tuberculosis
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV HIV/AIDS, Cardiovascular Disease
Effect of low dose methotrexate on endothelial function and inflammation in HIV HIV/AIDS, Cardiovascular Disease
Epidemiology and Pathogenesis of Pulmonary Hypertension in HIV Patients HIV/AIDS, Epidemiology and Surveillance
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV HIV/AIDS
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection HIV/AIDS, Cardiovascular Disease, Pharmacology and Drug Treatment
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
Specimens Related to the MU-UCSF Research Collaboration Laurence Huang, MD HIV/AIDS
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study Laurence Huang, MD HIV/AIDS
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis Laurence Huang, MD HIV/AIDS, Tuberculosis
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) Laurence Huang, MD HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD HIV/AIDS
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) Laurence Huang, MD HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD HIV/AIDS
PCP OPW Specimens Laurence Huang, MD Opportunistic Infection
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Laurence Huang, MD HIV/AIDS
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women Megan Huchko, MD HIV/AIDS, Cancer/Oncology
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection Peter Hunt, MD HIV/AIDS
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD HIV/AIDS, Cardiovascular Disease, Chronic Respiratory Disease, Aging
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Peter Hunt, MD HIV/AIDS
Mesalamine to Reduce T Cell Activation in HIV Infection Peter Hunt, MD HIV/AIDS, Drug and Diagnostics Development
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Peter Hunt, MD HIV/AIDS
Valganciclovir to Reduce T Cell Activation in HIV Infection Peter Hunt, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans Peter Hunt, MD HIV/AIDS
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa Peter Hunt, MD HIV/AIDS
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection Peter Hunt, MD HIV/AIDS
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans Peter Hunt, MD HIV/AIDS
HIV-Specific T-cell Responses in Rectal Mucosa Peter Hunt, MD HIV/AIDS
The Determinants of T Cell Activation in HIV Infection Peter Hunt, MD HIV/AIDS
HIV Pathogenesis and Immunity in Viremic Non-Progressors Peter Hunt, MD HIV/AIDS
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD HIV/AIDS, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART HIV/AIDS
HIV Emergence of Drug Resistance Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
AIDS Malignancies Consortium Lawrence Kaplan, MD HIV/AIDS, Cancer/Oncology
Mpowerment Project Training Agreement Susan Kegeles, PhD HIV/AIDS, Adolescent Health, Training and Capacity Building, Patient and Peer Education
HIV Prevention for Transgender Individuals Susan Kegeles, PhD HIV/AIDS, Engagement in Care
NIMH Collaborative HIV/STD Prevention Trial Susan Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science
Community-level HIV Prevention Intervention for Young Black Men Susan Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care
Development of a Multilevel HIV Prevention for Latin American Men Susan Kegeles, PhD HIV/AIDS
Multilevel HIV Prevention Intervention for Young African American Men Susan Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
HIV Prevention for African American Down Low Men Susan Kegeles, PhD HIV/AIDS, Engagement in Care, Risk Reduction and Prevention, Patient and Peer Education
Faith-based HIV Prevention for African American MSM Susan Kegeles, PhD HIV/AIDS
Community Mobilization to Improve the HIV/AIDS Continuum of Care among Black Men Susan Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
HIV Translation Research for Young African American MSM Susan Kegeles, PhD HIV/AIDS, Access or Barriers to Care, Engagement in Care, Risk Reduction and Prevention
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD HIV/AIDS, Neurology and Mental Health, Implementation and Behavioral Science, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Moving a Research-Based Intervention into Practice Susan Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention
Web-Based, Structural HIV Prevention in MSM's Networks Susan Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
NIMH Collaborative HIV/STD Prevention Trial Susan Kegeles, PhD HIV/AIDS
HIV Prevention for African American Down Low Men Susan Kegeles, PhD HIV/AIDS, Engagement in Care
NIMH Collaborative HIV/STD Prevention Trial Susan Kegeles, PhD HIV/AIDS
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD HIV/AIDS
Mpowerment Project Training Agreement Susan Kegeles, PhD HIV/AIDS, Training and Capacity Building, Patient and Peer Education
Mpowerment Project Training Agreement Susan Kegeles, PhD HIV/AIDS, Adolescent Health, Risk Reduction and Prevention, Patient and Peer Education
Innate Immunity and Autophagy in Elite Controllers HIV/AIDS
Studies of Ocular Complications of AIDS (SOCA) HIV/AIDS, Eye Disease and Blindness
Integrated Biological and Behavioral Surveillance (IBBS) with Population Size Estimation using Respondent Driven Sampling (RDS) among Men who have Sex with Men (MSM) in South Africa Timothy Lane, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Triangulation
Integrated Biological Behavioral Survey with Population Size Estimation using Respondent Driven Sampling among Men who have sex with Men Timothy Lane, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Triangulation
HIV Evaluation Activities with High-Risk, Underserved Populations in South Africa Timothy Lane, PhD, MPH HIV/AIDS, Implementation and Behavioral Science
HIV Evaluation Activities with High Risk Underserved Populations in South Africa under PEPFAR Timothy Lane, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan Timothy Lane, PhD, MPH HIV/AIDS, Tuberculosis, Access or Barriers to Care, Stigma and Discrimination
HIV Prevention among High-Risk Men in South Africa Timothy Lane, PhD, MPH HIV/AIDS
Health Empowerment for MSM in South Africa Timothy Lane, PhD, MPH HIV/AIDS
Protection from HIV Infection in Intravenous Drug Users HIV/AIDS, Substance Abuse, Risk Reduction and Prevention
Identification of the CD8+ Cell Anti-HIV Factor (CAF) HIV/AIDS, Immunology
UCSF AIDS Research Training Program HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Identification of the CD8+ Cell Antiviral Factor (CAF) HIV/AIDS
Identification of the CD8 Cell Anti-HIV Factor (CAF) HIV/AIDS
Subcontract from UFL Prime: HIV/FIV-Cat-Model: A model to identify vaccine epitopes HIV/AIDS
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
Immunologic and Virologic Features of Early HIV Infection HIV/AIDS, Risk Reduction and Prevention
HIV cure with CCR5 (-) human IPS hematopoietic stem cells HIV/AIDS, Risk Reduction and Prevention
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
Molecular Epidemiology of the Human Immunodeficiency Virus in Mexico HIV/AIDS
JCF/Bransten Grant HIV/AIDS
JCF/Hellman Grant HIV/AIDS
HIV cure with CCR5 negative human IPS hematopoietic stem cells HIV/AIDS, Drug and Diagnostics Development, Immunology
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
Prevention Umbrella for MSM in the Americas Sheri Lippman, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
Self-Conducted HIV Tests - Improving HIV Prevention in Key Populations Sheri Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care, Engagement in Care
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services Sheri Lippman, PhD, MPH HIV/AIDS, Systematic Reviews and Guideline Development
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services Sheri Lippman, PhD, MPH HIV/AIDS
Toward Understanding Community Mobilization for HIV Prevention in the African Context Sheri Lippman, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
Copy of Innovations in HIV testing to enhance care for young women and their partners Sheri Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Anne Luetkemeyer, MD HIV/AIDS
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1 Anne Luetkemeyer, MD HIV/AIDS
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects Anne Luetkemeyer, MD HIV/AIDS
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s Anne Luetkemeyer, MD HIV/AIDS
Gilead GS-US-236-0102 Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne Luetkemeyer, MD HIV/AIDS, Tuberculosis
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255 Anne Luetkemeyer, MD HIV/AIDS
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV Anne Luetkemeyer, MD HIV/AIDS
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men Anne Luetkemeyer, MD HIV/AIDS, Cancer/Oncology
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Pfizer A4001027: Observational Phase Extension Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected Anne Luetkemeyer, MD HIV/AIDS
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:) Anne Luetkemeyer, MD HIV/AIDS
Unsolicited R24 for the CFAR - Network of Integrated Clinical Sciences (CNICS) Jeffrey Martin, MD, MPH HIV/AIDS
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Gilead Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS
Uganda-UCSF Research Training Program in HIV-Associated Malignancies Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Cohort Study of Patients Receiving Long-Term Combination Therapy [II] Jeffrey Martin, MD, MPH HIV/AIDS, Drug and Diagnostics Development
Novel Approaches to Monitoring and Utilizing Adherence to HIV Therapy in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH HIV/AIDS
Implementation science to optimize HIV prevention in East Africa PEPFAR program Jeffrey Martin, MD, MPH HIV/AIDS
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH HIV/AIDS
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
NAAccord (CHK-UP on HIV Supplement) Jeffrey Martin, MD, MPH HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease
East Africa IEDEA Regional Consortium Jeffrey Martin, MD, MPH HIV/AIDS
Effects of Maraviroc on HIV-related Kaposi Sarcoma Toby Maurer, MD HIV/AIDS, Cancer/Oncology
HIV, Hepatitis C, and Pruritus: Data from the Women's Interagency HIV Study Toby Maurer, MD Infectious Disease, HIV/AIDS, Women's Health
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging Toby Maurer, MD HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection Toby Maurer, MD HIV/AIDS, Cancer/Oncology
Disulfiram Interactions With HIV Medications: Clinical Implications HIV/AIDS
Role of Buprenorphine in Improving Clinicial Care in Opioid Addiction and HIV HIV/AIDS, Pharmacology and Drug Treatment, Substance Abuse
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection HIV/AIDS
Opioids & HIV Medications: Interactions in Drug Abusers HIV/AIDS
Inflammation and HIV Persistence Mike McCune, MD, PhD HIV/AIDS
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1 Mike McCune, MD, PhD HIV/AIDS, Immunology
HIV Proteomic Center for Host-Viral Responses Characterization Mike McCune, MD, PhD HIV/AIDS
Detection and Measurement of the HIV Reservoir Mike McCune, MD, PhD HIV/AIDS
Assessing Laboratory Correlates of Immune Protection Mike McCune, MD, PhD HIV/AIDS
HIV Proteomic Center for Host-Viral Responses Characterization Mike McCune, MD, PhD HIV/AIDS
Thymic Function in Adults With HIV-1 Disease Mike McCune, MD, PhD HIV/AIDS
Interruption of Maternal-Fetal Transmission of HIV Mike McCune, MD, PhD HIV/AIDS, Women's Health
HIV Effects on the Central Hematolymphoid System Mike McCune, MD, PhD HIV/AIDS
Exchange of samples- Placental Biopsies Mike McCune, MD, PhD HIV/AIDS, Women's Health
Novel flow cytometry-based assay for HIV-infected cells Mike McCune, MD, PhD HIV/AIDS, Risk Reduction and Prevention
HIV Effects on the Central Hematolymphoid System Mike McCune, MD, PhD HIV/AIDS
Defining critical events in early HIV infection-effects of alcohol and early ART Mike McCune, MD, PhD HIV/AIDS, Immunology, Substance Abuse